Please ensure Javascript is enabled for purposes of website accessibility
Horizon Therapeutics Stock Quote

Horizon Therapeutics (NASDAQ: HZNP)

Price as of March 24, 2023, 10:00 a.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Horizon Therapeutics Returns vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
HZNP -1.17% +682.97% +50.85% +1,086%
S&P -12.15% +53.42% +8.93% +205%

Horizon Therapeutics Company Info

Horizon Therapeutics is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis pain and inflammatory diseases.

News & Analysis

The Fool has written over 100 articles on Horizon Therapeutics.

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 03/27/2023.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.